Use

This panel assesses biochemical markers of metabolic syndrome, insulin resistance, and glucose control to evaluate patient risk for type 2 diabetes, cardiovascular disease, and related comorbidities. It includes components such as glucose, lipids, insulin (intact), and an insulin resistance risk score to aid early detection and intervention.